Hypertrophic cardiomyopathy is an underdiagnosed genetic disorder, resulting from mutations in sarcomeric proteins. It has a highly variable clinical presentation, with some individuals remaining ...
The FDA has approved the drug Camzyos to treat obstructive hypertrophic cardiomyopathy (HCM). A second drug is currently under review. Other medications and lifestyle strategies can also help manage ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback